.png "Cedars-Sinai"){kind=logo}
Walsh Lab
Christine Walsh, MD, MS, is a physician-scientist in the Cedars-Sinai Division of Gynecologic Oncology. As a physician, she recognizes and seeks to understand the variability in the biologic behavior of different cancers that transcends the currently used pathologic metrics of grade, histology and stage. She studies the genetic changes occurring in ovarian cancer DNA, with the goals of better defining the events that lead to ovarian cancer initiation and progression, and identifying novel therapeutic targets and treatments. The ultimate goal of her work is to identify novel molecular targets that can be inhibited in order to restore platinum sensitivity to chemo resistant ovarian cancers and to improve on the prognosis of women affected with this lethal malignancy.
The Walsh Laboratory is affiliated with the Samuel Oschin Comprehensive Cancer Institute and the Division of Gynecologic Oncology in Gynecology.
- Reversing platinum resistance
- Modeling the genetic heterogeneity of ovarian cancer
- Clinical questions in gynecologic oncology
Meet Our Team
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Walsh Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Hodeib M, Cohen JG, Mehta S, Rimel BJ, Walsh CS, Li AJ, Karlan BY, Cass I.
Gynecol Oncol. 2016 Jun;141(3):507-510.
Beach JA, Aspuria PJ, Cheon DJ, Lawrenson K, Agadjanian H, Walsh CS, Karlan BY, Orsulic S.
Oncotarget. 2016 Jan 26;7(4):4167-4182.
Walsh CS, Hodeib M.
Curr Opin Obstet Gynecol. 2016 Feb;28(1):24-31.
Contact the Walsh Lab
8700 Beverly Blvd.
West Tower, Suite 160W
Los Angeles, CA 90048